254 related articles for article (PubMed ID: 30786729)
61. Identification of EDNRA as the Key Biomarker for Hypercholesterolemia and Colorectal Cancer.
Han K; He Z; Liu Y; Chen H
Tohoku J Exp Med; 2024 Mar; 262(3):181-189. PubMed ID: 38123303
[TBL] [Abstract][Full Text] [Related]
62. Bioinformatics Analysis Identifies Hub Genes and Molecular Pathways Involved in Sepsis-Induced Myopathy.
Ning YL; Yang ZQ; Xian SX; Lin JZ; Lin XF; Chen WT
Med Sci Monit; 2020 Feb; 26():e919665. PubMed ID: 32008037
[TBL] [Abstract][Full Text] [Related]
63. Possible Molecular Markers for the Diagnosis of Pancreatic Ductal Adenocarcinoma.
Shen Q; Yu M; Jia JK; Li WX; Tian YW; Xue HZ
Med Sci Monit; 2018 Apr; 24():2368-2376. PubMed ID: 29671412
[TBL] [Abstract][Full Text] [Related]
64. Identification of a five-gene signature with prognostic value in colorectal cancer.
Sun G; Li Y; Peng Y; Lu D; Zhang F; Cui X; Zhang Q; Li Z
J Cell Physiol; 2019 Apr; 234(4):3829-3836. PubMed ID: 30132881
[TBL] [Abstract][Full Text] [Related]
65. Identification of Hub Genes Associated with Tumor-Infiltrating Immune Cells and ECM Dynamics as the Potential Therapeutic Targets in Gastric Cancer through an Integrated Bioinformatic Analysis and Machine Learning Methods.
Liu J; Cheng Z
Comb Chem High Throughput Screen; 2023; 26(4):653-667. PubMed ID: 35996248
[TBL] [Abstract][Full Text] [Related]
66. Identification of Potential Key Genes and Pathways in Enzalutamide-Resistant Prostate Cancer Cell Lines: A Bioinformatics Analysis with Data from the Gene Expression Omnibus (GEO) Database.
Zheng L; Dou X; Ma X; Qu W; Tang X
Biomed Res Int; 2020; 2020():8341097. PubMed ID: 32724813
[TBL] [Abstract][Full Text] [Related]
67. Screening and Identification of Key Biomarkers in Inflammatory Breast Cancer Through Integrated Bioinformatic Analyses.
Wu J; Lv Q; Huang H; Zhu M; Meng D
Genet Test Mol Biomarkers; 2020 Aug; 24(8):484-491. PubMed ID: 32598242
[No Abstract] [Full Text] [Related]
68. In silico analysis to identify miR-1271-5p/PLCB4 (phospholipase C Beta 4) axis mediated oxaliplatin resistance in metastatic colorectal cancer.
Lee CC; Lee AW; Wei PL; Liu YS; Chang YJ; Huang CY
Sci Rep; 2023 Mar; 13(1):4366. PubMed ID: 36927770
[TBL] [Abstract][Full Text] [Related]
69. Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis.
Hu S; Liao Y; Chen L
Med Sci Monit; 2018 Sep; 24():6438-6448. PubMed ID: 30213925
[TBL] [Abstract][Full Text] [Related]
70. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
[TBL] [Abstract][Full Text] [Related]
71. Identification of Key Genes and Pathways in Osteosarcoma by Bioinformatics Analysis.
Chen X; Zhang N; Zheng Y; Tong Z; Yang T; Kang X; He Y; Dong L
Comput Math Methods Med; 2022; 2022():7549894. PubMed ID: 35075370
[TBL] [Abstract][Full Text] [Related]
72. Identification of Differentially Expressed Genes and Signaling Pathways in Acute Myocardial Infarction Based on Integrated Bioinformatics Analysis.
Chen DQ; Kong XS; Shen XB; Huang MZ; Zheng JP; Sun J; Xu SH
Cardiovasc Ther; 2019; 2019():8490707. PubMed ID: 31772617
[TBL] [Abstract][Full Text] [Related]
73. CDK1 and CDC20 overexpression in patients with colorectal cancer are associated with poor prognosis: evidence from integrated bioinformatics analysis.
Li J; Wang Y; Wang X; Yang Q
World J Surg Oncol; 2020 Mar; 18(1):50. PubMed ID: 32127012
[TBL] [Abstract][Full Text] [Related]
74. Protein-protein interaction networks and modules analysis for colorectal cancer and serrated adenocarcinoma.
Yu H; Ye L; Wang J; Jin L; Lv Y; Yu M
J Cancer Res Ther; 2015; 11(4):846-51. PubMed ID: 26881529
[TBL] [Abstract][Full Text] [Related]
75. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
76. Identification of hub genes, pathways, and related transcription factors in systemic lupus erythematosus: A preliminary bioinformatics analysis.
Wang Y; Ma Q; Huo Z
Medicine (Baltimore); 2021 Jun; 100(25):e26499. PubMed ID: 34160465
[TBL] [Abstract][Full Text] [Related]
77. Identification of disrupted pathways in ulcerative colitis-related colorectal carcinoma by systematic tracking the dysregulated modules.
Wu D; Li Q; Song G; Lu J
J BUON; 2016; 21(2):366-74. PubMed ID: 27273946
[TBL] [Abstract][Full Text] [Related]
78. Hub genes and pathways in gastric cancer: A comparison between studies that used normal tissues adjacent to the tumour and studies that used healthy tissues as calibrator.
Sadegh K; Ahmadi A
IET Syst Biol; 2023 Jun; 17(3):131-141. PubMed ID: 37118990
[TBL] [Abstract][Full Text] [Related]
79. Comprehensive Analysis of Core Genes and Potential Mechanisms in Rectal Cancer.
Liu BX; Huang GJ; Cheng HB
J Comput Biol; 2019 Nov; 26(11):1262-1277. PubMed ID: 31211595
[No Abstract] [Full Text] [Related]
80. Identification and Interaction Analysis of Molecular Markers in Colorectal Cancer by Integrated Bioinformatics Analysis.
Han B; Feng D; Yu X; Zhang Y; Liu Y; Zhou L
Med Sci Monit; 2018 Aug; 24():6059-6069. PubMed ID: 30168505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
